BIORCHESTRA
BIORCHESTRA is a developer of RNA-based therapeutics.
BIORCHESTRA
Social Links:
Industry:
Biopharma Health Care Medical Therapeutics
Founded:
2016-10-18
Address:
Yusong, Taejon-jikhalsi, South Korea
Country:
South Korea
Website Url:
http://www.biorchestra.com
Total Employee:
1+
Status:
Active
Contact:
042-863-1013
Email Addresses:
[email protected]
Total Funding:
45 M USD
Technology used in webpage:
SPF LetsEncrypt Nginx Microsoft Exchange Online Office 365 Mail AJAX Libraries API Sectigo SSL Sectigo Domain SSL LocalBusiness Schema RawGit
Similar Organizations
C4 Therapeutics
C4 Therapeutics develops novel early stage therapies that eliminate disease-causing proteins.
Dyne Therapeutics
Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.
Gracell Biotechnologies
Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer.
Nutcracker Therapeutics
Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Current Employees Featured
Founder
Investors List
Smilegate Investment
Smilegate Investment investment in Series C - BIORCHESTRA
E&Venture Partners
E&Venture Partners investment in Series C - BIORCHESTRA
SBI Investment
SBI Investment investment in Series C - BIORCHESTRA
IMM Investment
IMM Investment investment in Series C - BIORCHESTRA
Widwin Investment
Widwin Investment investment in Series C - BIORCHESTRA
Quantum Ventures Korea
Quantum Ventures Korea investment in Series C - BIORCHESTRA
GS Holdings
GS Holdings investment in Series C - BIORCHESTRA
Dayli Partners
Dayli Partners investment in Series C - BIORCHESTRA
LSK Investment
LSK Investment investment in Series C - BIORCHESTRA
STIC Investment
STIC Investment investment in Series C - BIORCHESTRA
Key Employee Changes
| Date | New article |
|---|---|
| 2021-09-23 | BIORCHESTRA appoints pharma veteran and Moderna and Akcea (Ionis) CMO "Dr. Louis St. L. O'Dea" as CMO of BIORCHESTRA |
Official Site Inspections
http://www.biorchestra.com Semrush global rank: 2.92 M Semrush visits lastest month: 5.58 K
- Host name: 183.111.199.182
- IP address: 183.111.199.182
- Location: South Korea
- Latitude: 37.5112
- Longitude: 126.9741
- Timezone: Asia/Seoul
More informations about "BIORCHESTRA"
BIORCHESTRA
๋ฐ์ด์ค ์ค์ผ์คํธ๋ผ๋ ํ์ ์ ์ธ ์ฝ๋ฌผ ์ ๋ฌ ์์คํ ๊ณผ ์ ๋ ์ฝ๋ฌผ ํ๋ณด๋ฅผ ๊ฐ๋ฐํ๋ ๋ฐ์ด์ค ๊ธฐ์ ํ์ฌ์ ๋๋ค.See details»
BIORCHESTRA - Crunchbase Company Profile & Funding
BIORCHESTRA is a biotech company that develops RNA-based therapeutics for treating neuroinflammatory diseases. They focus on changing the therapeutic โฆSee details»
Biorchestra 2025 Company Profile: Valuation, Funding ... - PitchBook
Biorchestra General Information Description. Developer of RNA-based therapeutics designed for the treatment of neurodegenerative and rare genetic diseases. The company's platform โฆSee details»
BIORCHESTRA Co., Ltd. Overview | SignalHire Company Profile
BIORCHESTRA is an innovative biotech company focusing on research and development of ribonucleic acid (RNA) based therapeutics. ... Organization Website. biorchestra.com . Phone โฆSee details»
BIORCHESTRA - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors ... Dec 16, 2020: Series B - BIORCHESTRA . 2: obfuscated. โฆSee details»
BIORCHESTRA - Contacts, Employees, Board Members, Advisors
BIORCHESTRA creates novel RNA-based therapeutics that will usher in a new era of treatment for neurodegenerative diseases. ... Pricing. Log In. Log In. Experience the new Crunchbase, โฆSee details»
BIORCHESTRA - 2025 Company Profile - Tracxn
Mar 7, 2025 BIORCHESTRA - Developer of RNA based medicines for treating neurodegnerative disease. Raised a total funding of $45M over 1 round from 15 investors. Founded by JH Ryu โฆSee details»
Biorchestra Co., Ltd. - VentureRadar
BIORCHESTRA, with offices in Daejeon, South Korea, and Cambridge, Massachusetts, USA, is an innovative biotech developing ribonucleic acid (RNA) based therapeutics. Our goal is to โฆSee details»
Biorchestra Co., Ltd. - Drug pipelines, Patents, Clinical trials
Explore Biorchestra Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 8 news, and 15 literature, Disease Domain:Nervous System Diseases, Endocrinology and Metabolic โฆSee details»
Biorchestra - Work in biotech
Biorchestra is developing treatments for neurodegenerative and rare central nervous system diseases. Their proprietary Brain Targeting Drug Delivery System platform technology enables โฆSee details»
Biorchestra, Inc. | BIO-Europe Spring - Informa Connect
Biorchestra specializes in innovative RNA therapeutics for neurodegenerative and other disorders. Our IV-formulated RNA medicines platform combines multiple modalities, chemistry โฆSee details»
BIORCHESTRA - Org Chart, Teams, Culture & Jobs - The Org
View BIORCHESTRA's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
BIORCHESTRA Expands Executive Leadership Team with the โฆ
Apr 5, 2023 About Biorchestra Drug Delivery System (BDDS TM) Formulated for IV administration, the BDDS TM platform targets an amino acid receptor in the blood-brain barrier โฆSee details»
BIORCHESTRA - BIO International Convention | BIO
Jun 8, 2023 The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ...See details»
BIORCHESTRA - Updates, News, Events, Signals & Triggers
BIORCHESTRA is focused on developing RNA-based therapeutics targeting neurodegenerative diseases. Their research includes miR-485 inhibitors, which are used to treat disorders linked โฆSee details»
Biorchestra - BIO International Convention 2025
Lead Product in Development: Biorchestra introduces a groundbreaking ASO therapy, BMD-001s, utilizing our innovative BDDS technology for IV delivery, offering unparalleled targeting within โฆSee details»
BIORCHESTRA receives Citation from the Korean Minister of Trade ...
BOSTON, Dec. 15, 2022 /PRNewswire/ -- BIORCHESTRA ("BIORCHESTRA" or the "Company"), a RNA therapeutics company with offices in Daejeon, South Korea, and Cambridge, โฆSee details»
Biorchestra - Endless Frontier Labs
Biorchestra is dedicated to treating Alzheimerโs disease by restoring brain cell functions using epigenetic modification. Biorchestraโs RNA-based epigenetic regulator is delivered into the โฆSee details»
BIORCHESTRA - Crunchbase
Organization. BIORCHESTRA . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Similar Companies. Edit Similar Companies โฆSee details»
BIORCHESTRA Announces 45 Million USD Series C Fundraising
Feb 23, 2022 BIORCHESTRA, with offices in Daejeon, South Korea, and Cambridge, Massachusetts, USA, is an innovative biotech developing ribonucleic acid (RNA) based โฆSee details»